Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 133761 - 133780 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01XC03) trastuzumab | HERCEPTIN | 600MG, 600MG INJ SOL VIA 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XC03) trastuzumab | HERCEPTIN | 150MG, 150MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XC03) trastuzumab | OGIVRI | 150MG, 150MG INF PLV CSL 1 , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | BiosimilarCollaborationsIrelandLimited,Dublin |
| Czech Republic | (L01XC03) trastuzumab | TRAZIMERA | 150MG, 150MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01XC06) cetuximab | ERBITUX | 5MG/ML, 5MG/ML INF SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01XC06) cetuximab | ERBITUX | 5MG/ML, 5MG/ML INF SOL 1X100ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01XC12) brentuximab vedotin | ADCETRIS | 50MG, 50MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Hodgkin Disease | TakedaPharmaA/S,VallensbaekStrand |
| Czech Republic | (L01XC13) pertuzumab | PERJETA | 420MG, 420MG INF CNC SOL 1X14ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XC15) obinutuzumab | GAZYVARO | 1000MG, 1000MG INF CNC SOL 1X40ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XC23) elotuzumab | EMPLICITI | 300MG, 300MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01XC23) elotuzumab | EMPLICITI | 400MG, 400MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01XC24) daratumumab | DARZALEX | 20MG/ML, 20MG/ML INF CNC SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XC24) daratumumab | DARZALEX | 20MG/ML, 20MG/ML INF CNC SOL 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XC26) inotuzumab ozogamicin | BESPONSA | 1MG, 1MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01XC31) avelumab | BAVENCIO | 20MG/ML, 20MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01XC38) isatuximab | SARCLISA | 20MG/ML, 20MG/ML INF CNC SOL 1X25ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie,Gentilly |
| Czech Republic | (L01XC38) isatuximab | SARCLISA | 20MG/ML, 20MG/ML INF CNC SOL 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie,Gentilly |
| Czech Republic | (L01XC39) belantamab mafodotin | BLENREP | 100MG, 100MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | GlaxoSmithKline(Ireland)Limited,Dublin |
| Czech Republic | (L01XE01) imatinib | GLIVEC | 100MG, 100MG TBL FLM 60 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01XE01) imatinib | GLIVEC | 100MG, 100MG TBL FLM 60 II , BLI | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited,Dublin |
Pages
